| Abstrakt: |
Keywords for this news article include: Manchester, United Kingdom, Europe, Anemia, Beta-Globulins, Blood Coagulation Factors, Blood Proteins, Fibrinolysis, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Peptides, Plasminogen, Plasminogen Activator Inhibitor 2, Plasminogen Activators, Plasminogen Inactivators, Proteins, Sickle Cell Anemia, University of Salford. Keywords: Manchester; United Kingdom; Europe; Anemia; Beta-Globulins; Blood Coagulation Factors; Blood Proteins; Fibrinolysis; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Peptides; Plasminogen; Plasminogen Activator Inhibitor 2; Plasminogen Activators; Plasminogen Inactivators; Proteins; Sickle Cell Anemia EN Manchester United Kingdom Europe Anemia Beta-Globulins Blood Coagulation Factors Blood Proteins Fibrinolysis Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Peptides Plasminogen Plasminogen Activator Inhibitor 2 Plasminogen Activators Plasminogen Inactivators Proteins Sickle Cell Anemia 373 373 1 08/07/23 20230807 NES 230807 2023 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in Hematologic Diseases and Conditions - Sickle Cell Anemia. [Extracted from the article] |
